Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 3Not yet recruiting 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 52Neoplasms 41Carcinoma, Non-Small-Cell Lung 34Prostatic Neoplasms 33Colorectal Neoplasms 32Lung Neoplasms 29Pancreatic Neoplasms 20Ovarian Neoplasms 17Multiple Myeloma 16Recurrence 15Uterine Cervical Neoplasms 13Neoplasm Metastasis 12Leukemia, Myeloid, Acute 12Carcinoma, Hepatocellular 12Melanoma 11Head and Neck Neoplasms 11Brain Neoplasms 11Endometrial Neoplasms 10Small Cell Lung Carcinoma 9Triple Negative Breast Neoplasms 8Stomach Neoplasms 8Rectal Neoplasms 8Glioblastoma 8Cholangiocarcinoma 8Carcinoma, Renal Cell 8Squamous Cell Carcinoma of Head and Neck 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Advanced Solid Tumors 7Lymphoma, Follicular 6Hematologic Neoplasms 6

Interventions

resiniferatoxin 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Cancer Pain × 30 days × Clear all
NCT07605546 2026-06-04

FREEDOM

Jonsson Comprehensive Cancer Center

Phase NA Not yet recruiting
19 enrolled

Cancer Pain

NCT02522611 2026-06-01

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

National Institutes of Health Clinical Center (CC)

Phase 1/2 Not yet recruiting
30 enrolled

Cancer Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡